Functional analysis of agalactosyl IgG in inflammatory bowel disease patients

Background: Agalactosyl immunoglobulin (Ig) G is increased in inflammatory bowel disease (IBD) similarly to rheumatoid arthritis (RA). The lectin complement pathway is shown to be activated through association of agalactosyl IgG with mannan‐binding lectin (MBL) in RA. Functional changes of IgG agalactosylation in IBD, however, have not yet been clarified. Methods: The ratio of the agalactosyl/non‐agalactosyl fraction in fucosylated IgG oligosaccharides (G0F/G2F) and serum MBL levels were analyzed in 59 patients with Crohn's disease (CD), 64 ulcerative colitis (UC), and 39 healthy volunteers (HV). The MBL levels associated with serum IgG were analyzed by enzyme‐linked immunosorbent assay. MBL expression in the intestinal mucosa was analyzed by immunohistochemistry. Phagocytosis of sheep red blood cells (SRBC) reacted with either an agalactosyl or non‐agalactosyl SRBC‐specific IgG antibody was determined by flow cytometry. Results: The serum MBL levels were not significantly different among CD, UC, or HV. In patients with CD, the serum MBL levels were negatively correlated with the Crohn's Disease Activity Index (CDAI). The levels of MBL associated with agalactosyl IgG were not different from those associated with non‐agalactosyl IgG. Immunoreactivity to MBL was less in the inflamed mucosa compared with the noninflamed mucosa. Phagocytic activity of SRBC was significantly higher in the presence of agalactosyl IgG compared to non‐agalactosyl IgG. Conclusions: Agalactosyl IgG oligosaccharides enhanced antibody‐dependent phagocytosis in vitro but did not activate the lectin complement pathway. Oligosaccharide alterations of IgG are not only a marker of IBD but also functionally modulate the immune function of IBD. (Inflamm Bowel Dis 2010;)

[1]  E. Szigethy,et al.  Inflammatory bowel disease. , 2011, Pediatric clinics of North America.

[2]  A. Schoepfer,et al.  Low Mannan-Binding Lectin Serum Levels Are Associated With Complicated Crohn's Disease and Reactivity to Oligomannan (ASCA) , 2009, The American Journal of Gastroenterology.

[3]  T. Kanda,et al.  Antibody-dependent enhancement of adeno-associated virus infection of human monocytic cell lines. , 2008, Virology.

[4]  N. Hayashi,et al.  IgG Oligosaccharide Alterations Are a Novel Diagnostic Marker for Disease Activity and the Clinical Course of Inflammatory Bowel Disease , 2008, The American Journal of Gastroenterology.

[5]  S. Carding,et al.  Inflammatory bowel disease: cause and immunobiology , 2007, The Lancet.

[6]  H. Drummond,et al.  Smoking Habit and Load Influence Age at Diagnosis and Disease Extent in Ulcerative Colitis , 2007, The American Journal of Gastroenterology.

[7]  B. Sands.  Inflammatory bowel disease: past, present, and future , 2007, Journal of Gastroenterology.

[8]  J. Szechiński,et al.  Galactosylation of IgG from rheumatoid arthritis (RA) patients – changes during therapy , 2006, Glycoconjugate Journal.

[9]  R. Dwek,et al.  Mannan binding lectin and its interaction with immunoglobulins in health and in disease. , 2006, Immunology letters.

[10]  S. Thiel,et al.  Hormonal regulation of mannan‐binding lectin synthesis in hepatocytes , 2006, Clinical and experimental immunology.

[11]  J. Ravetch,et al.  Fcgamma receptors: old friends and new family members. , 2006, Immunity.

[12]  J. Ravetch,et al.  Fcgamma receptors: old friends and new family members. , 2006, Immunity.

[13]  C. Figdor,et al.  Levels of complexity in pathogen recognition by C-type lectins , 2005, Current Opinion in Immunology.

[14]  H. Ogata,et al.  Novel pathophysiological concepts of inflammatory bowel disease , 2005, Journal of Gastroenterology.

[15]  F. Seibold,et al.  Genetic variants of the mannan-binding lectin are associated with immune reactivity to mannans in Crohn's disease. , 2004, Gastroenterology.

[16]  D. Jack,et al.  Mannose-Binding Lectin Binds to Two Major Outer Membrane Proteins, Opacity Protein and Porin, of Neisseria meningitidis1 , 2004, The Journal of Immunology.

[17]  M. Turner,et al.  The role of mannose-binding lectin in health and disease. , 2003, Molecular immunology.

[18]  O. Dewit,et al.  Serological markers in inflammatory bowel diseases. , 2003, Best practice & research. Clinical gastroenterology.

[19]  T. Geijtenbeek,et al.  Mycobacteria Target DC-SIGN to Suppress Dendritic Cell Function , 2003, The Journal of experimental medicine.

[20]  G. Baatrup,et al.  Complement activation in plasma before and after Infliximab treatment in Crohn disease , 2003, Scandinavian journal of gastroenterology.

[21]  S. Thiel,et al.  L-MBP Is Expressed in Epithelial Cells of Mouse Small Intestine1 , 2002, The Journal of Immunology.

[22]  Jonathan Braun,et al.  Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens. , 2002, Gastroenterology.

[23]  C. Anderson,et al.  Regulated Expression and Inhibitory Function of FcγRIIb in Human Monocytic Cells* , 2002, The Journal of Biological Chemistry.

[24]  P. Lemey,et al.  Mannan-binding lectin (MBL) gene polymorphisms in ulcerative colitis and Crohn’s disease , 2001, Genes and Immunity.

[25]  S. Targan,et al.  Identification of a novel bacterial sequence associated with Crohn's disease. , 2000, Gastroenterology.

[26]  E. Jirillo,et al.  Phagocytosis, killing, lymphocyte-mediated antibacterial activity, serum autoantibodies, and plasma endotoxins in inflammatory bowel disease , 2000, American Journal of Gastroenterology.

[27]  S. Targan,et al.  Colonic Bacteria Express an Ulcerative Colitis pANCA-Related Protein Epitope , 2000, Infection and Immunity.

[28]  D. Jack,et al.  Mannose-Binding Lectin Binds to a Range of Clinically Relevant Microorganisms and Promotes Complement Deposition , 2000, Infection and Immunity.

[29]  R. Dwek,et al.  Two edged role of mannose binding lectin in rheumatoid arthritis: a cross sectional study. , 2000, The Journal of rheumatology.

[30]  R. Blumberg,et al.  Animal models of mucosal inflammation and their relation to human inflammatory bowel disease. , 1999, Current opinion in immunology.

[31]  R. Salter,et al.  Binding and uptake of agalactosyl IgG by mannose receptor on macrophages and dendritic cells. , 1999, Journal of immunology.

[32]  W. Ollier,et al.  Absence of an association between mannose-binding lectin polymorphism and rheumatoid arthritis. , 1998, British journal of rheumatology.

[33]  M. Turner,et al.  Mannose-binding lectin: the pluripotent molecule of the innate immune system. , 1996, Immunology today.

[34]  M. Turner.  The lectin pathway of complement activation. , 1996, Research in immunology.

[35]  S. Thiel,et al.  Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. , 1995, Journal of immunology.

[36]  R. Dwek,et al.  Glycosylation changes of IgG associated with rheumatooid arthritis can activate complement via the mannose-binding protein , 1995, Nature Medicine.

[37]  R. Dwek,et al.  Agalactosyl glycoforms of IgG autoantibodies are pathogenic. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[38]  M. Kiso,et al.  Analysis of oligosaccharides of human IgG from serum of leukemia patients. , 1994, Biochemistry and molecular biology international.

[39]  T. Fujita,et al.  Activation of the classical complement pathway by mannose-binding protein in association with a novel C1s-like serine protease , 1992, The Journal of experimental medicine.

[40]  D. Podolsky,et al.  Inflammatory bowel disease (1) , 1991, The New England journal of medicine.

[41]  S. Thiel,et al.  ASSOCIATION OF LOW LEVELS OF MANNAN-BINDING PROTEIN WITH A COMMON DEFECT OF OPSONISATION , 1989, The Lancet.

[42]  Ami,et al.  Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. , 1989, BMJ.

[43]  J. Lennard-jones,et al.  Classification of inflammatory bowel disease. , 1989, Scandinavian journal of gastroenterology. Supplement.

[44]  R. Dwek,et al.  GALACTOSYLATION OF IgG ASSOCIATED OLIGOSACCHARIDES: REDUCTION IN PATIENTS WITH ADULT AND JUVENILE ONSET RHEUMATOID ARTHRITIS AND RELATION TO DISEASE ACTIVITY , 1988, The Lancet.

[45]  L. Opie.  Drugs and the heart. VI. Vasodilating drugs. , 1980, Lancet.

[46]  F Kern,et al.  Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. , 1976, Gastroenterology.

[47]  L. Hood,et al.  Attachment of carbohydrate to the variable region of myeloma immunoglobulin light chains. , 1970, Proceedings of the National Academy of Sciences of the United States of America.

[48]  I. Leodolter.  [Crohn's disease]. , 1967, Wiener Zeitschrift fur innere Medizin und ihre Grenzgebiete.